Published on 17/04/24 in the following categories Antimicrobials
Smaltis attends the 34th edition of the ECCMID international congress, renamed ESCMID Global, in Barcelona from April 27 to 30, 2024. This clinical microbiology and infectious diseases event is one of the largest and most important congresses in the field of infection, bringing together over 16,000 participants from all over the world to contribute to the dissemination of scientific knowledge.
The full scientific program is developed by the ESCMID Global Program Committee (EPC), an independent group of experts representing all disciplines related to clinical microbiology, infectious diseases, infection prevention and control, and public health. This rich and varied program covers the whole range of subjects in these fields, enabling scientific opinions to be compared and synergies to be created between advances made worldwide.
For Smaltis, the congress is an opportunity to keep abreast of the issues and challenges raised by infectious diseases, as well as their epidemiological aspects. Meeting with people involved in the development of new antimicrobial control strategies also gives Smaltis an overview of the ways being explored and solutions deployed to contain infectious epidemics, as well as an opportunity to study the relevant models for studying the effectiveness of these solutions.
News and articles
Legionella pneumophila: achieving homogeneity with a bacterium prone to aggregation
In this second episode dedicated to fastidious bacteria, let’s take a closer look at Legionella pneumophila. Its cultivation requires a specific medium, notably enriched with L-cysteine and iron. With this species, medium composition, incubation time, and the timing of readout directly influence bacterial recovery.
Characterization of PDRN in cosmetic active ingredients
PDRN is attracting growing interest in dermatology, aesthetic medicine, and the development of cosmetic active ingredients. Long associated with preparations derived from salmonids, PDRN is now also being investigated from plant and algal sources. This diversification of raw materials and production processes calls for characterization tailored to each preparation, in order to compare ingredients using documented scientific criteria and support their development.
Borrelia : quantitative precision at the heart of inoculum preparation
First episode dedicated to fastidious bacteria: Borrelia, the spirochetes responsible for borreliosis, or Lyme disease, for which accurate enumeration directly determines the quality of the inoculum.
At Smaltis, we work in particular with Borrelia afzelii, Borrelia burgdorferisensu stricto, and Borrelia garinii, three major species of the Borrelia burgdorferi sensu lato complex involved in borreliosis, or Lyme disease.
Cutibacterium acnes: when the strain matters as much as the species
À la surface de notre peau et au cœur des follicules pilo-sébacés vit une bactérie bien connue : Cutibacterium acnes. Particulièrement abondante dans les zones riches en sébum, cette bactérie à Gram positif et anaérobie aérotolérante est fréquemment associée à l’acné.
Pourtant, sa présence n’est pas en elle-même le signe d’un déséquilibre. C. acnes fait partie du microbiote cutané normal et se retrouve aussi bien sur une peau saine que sur une peau à tendance acnéique. Certaines études ont même montré que son abondance globale pouvait être relativement comparable dans ces deux situations.
Le rôle de C. acnes ne peut donc pas être compris en recherchant uniquement sa présence ou en mesurant sa quantité. Il dépend également de la composition de sa population, des propriétés des souches qui la constituent et de leurs interactions avec leur environnement.
Resistance of Pseudomonas aeruginosa to odilorhabdins: MexXY(OprM) at the heart of the bacterial response
Why can an antibiotic active against several Gram-negative bacteria lose much of its efficacy against Pseudomonas aeruginosa?
A study published in 2026 in Microbiology Spectrum, to which Smaltis contributed, provides new insights into this question. It shows that the MexXY(OprM) efflux pump plays a major role in the resistance of P. aeruginosa to odilorhabdins, a new class of antibiotics targeting the bacterial ribosome.
Beyond this finding, the study illustrates an essential reality in the development of new antimicrobials: knowing a compound’s target is not enough. It is also necessary to understand how the bacterium detects it, adapts to it, and organises its defence
Choosing the Right Strain to Build a Relevant Microbiological Model
In microbiology, a strain is never just another component of a protocol. It carries a genome, a history and an origin that determine what an experiment can truly reveal. Two strains belonging to the same species can therefore generate different results, all technically valid, yet not necessarily answering the same scientific question.
This is why, at Smaltis, strain selection is an integral part of experimental design. Before searching a collection or looking for a specific isolate, we first clarify the objective of the project: is the aim to standardize a method, understand a mechanism, evaluate an antimicrobial compound, reproduce a resistance phenotype, or represent a clinical situation? The answer then determines the most appropriate model: a reference strain, a human, veterinary or environmental isolate, a strain panel, an available mutant, or a custom-built strain.
Once upon a time, there was a scent so familiar that it was given its own name: petrichor.
It is the unmistakable fragrance that rises from the ground after the first drops of a summer rain fall onto dry soil. A comforting, almost universal scent that evokes woodland walks, gardens after a thunderstorm, or cherished childhood memories. For centuries, people simply believed it was the smell of wet earth. The truth, however, proved far more fascinating.
Management of Microbiological Contamination: Identifying, Understanding and Preventing Recurrence
Microbiological contamination is not limited to a non-compliant result. In R&D development, quality control, an industrial process or biological production, it immediately raises concrete questions: where does the contaminant come from, is it isolated or recurrent, what is its impact, and how can its reappearance be prevented?
The response is not simply to identify the bacterium and then restart the process. To achieve lasting control of bacterial contamination, the investigation must be able to connect laboratory observations with the real operational context: samples, flows, raw materials, equipment, cleaning, disinfection and field practices.
At Smaltis, we approach these situations as a structured microbiological investigation: understanding the problem, isolating the contaminants, identifying and comparing the isolates, preserving useful material, and then testing appropriate prevention solutions.
Skin Microbiome: Cultivating Rigor to Objectify Innovation
The skin microbiome is not mere scenery. It is a functional component of the skin, involved in protection against pathogens, immune dialogue, and the modulation of inflammation. It is a dynamic ecosystem shaped by subtle interactions between bacteria, yeasts, the host, and the environment.
Our approach is grounded in a simple conviction: understanding a microbiome is not merely about identifying it. It is about knowing how to culture it, interrogate it, and generate scientifically defensible data.
This is precisely how we approach the skin microbiome: as a complex ecosystem whose actors, dynamics, and mechanisms must be mastered before attempting to modulate its balance.
Once upon a time, in the hospitals of the twenty-first century, there was an infection that even antibiotics could no longer silence. An opportunistic infection caused by a bacterium called Clostridioides difficile, it often appeared in patients who were already vulnerable… and, above all, already heavily treated. Let us look back at the history of this infection, which gave rise to new therapeutic approaches.